[
    [
        {
            "time": "2018-07-17",
            "original_text": "【医药-乐普医疗(300003)】江琦、谢木青：阿托伐他汀钙通过一致性评价，药品业务进入收获期-20180717",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "阿托伐他汀钙",
                    "一致性评价",
                    "药品业务",
                    "收获期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药-乐普医疗(300003)】江琦、谢木青：阿托伐他汀钙通过一致性评价，药品业务进入收获期-20180717",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "今日涨停板股票预测：7月18日国企改革概念迎爆发契机",
            "features": {
                "keywords": [
                    "涨停板",
                    "国企改革",
                    "概念",
                    "爆发契机"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "今日涨停板股票预测：7月18日国企改革概念迎爆发契机",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "[买入评级]乐普医疗(300003)：阿托伐他汀通过一致性评价 夯实业绩增长点",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "阿托伐他汀",
                    "一致性评价",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[买入评级]乐普医疗(300003)：阿托伐他汀通过一致性评价 夯实业绩增长点",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "【医药|周小刚】乐普医疗(300003)：阿托伐他汀一致性评价即将获批，有望贡献显著利润增量",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "阿托伐他汀",
                    "一致性评价",
                    "利润增量"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药|周小刚】乐普医疗(300003)：阿托伐他汀一致性评价即将获批，有望贡献显著利润增量",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "【东吴晨报0718】【行业】电新【个股】地素时尚、星源材质、乐普医疗",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "东吴晨报",
                    "行业",
                    "个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【东吴晨报0718】【行业】电新【个股】地素时尚、星源材质、乐普医疗",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "医药生物行业日报：2018年抗癌药医保准入专项谈判将开展",
            "features": {
                "keywords": [
                    "医药生物",
                    "抗癌药",
                    "医保准入",
                    "专项谈判"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业日报：2018年抗癌药医保准入专项谈判将开展",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "[推荐评级]医药行业周报：医药反弹有望持续 重点关注业绩增长明确标的",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "反弹",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：医药反弹有望持续 重点关注业绩增长明确标的",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]